Neuropsychiatric aspects of cytokines research: An overview

Neuroscience and Biobehavioral Reviews

Volumn 20, Issue 3, 1996, Pages 359-365

  Malek Ahmadi, Parviz ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Central nervous system; Cytokine receptors; Cytokines; Immune system; Neuroglia; Neuropsychiatric disorders

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR;

BRAIN LEVEL; HUMAN; IMMUNOCOMPETENT CELL; MEDICAL RESEARCH; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029831358     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/0149-7634(95)00056-9     Document Type: Article

References (89)

1. Aggarwal B.B., Pocsik E. Cytokines: From clone to clinic. Arch. Biochem. Biophys. 292:1992;335-359.
2. Alstiel L.D., Sperber K. Cytokines in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 15:1991;481-495.
3. Araujo D.M., Lapchak P.A., Collier B., Quirion R. Localization of interleukin-2 immunoreactivity in the rat brain: Interaction with cholinergic system. Brain Res. 498:1989;257-266.
4. Banks W.A., Kastin A.J., Durham D.A. Bidirectional transport of interleukin-1α across the blood-brain barrier. Brain Res. Bull. 23:1989;433-437.
5. Bauer J., Hohagen F., Ebert T., Timmer J., Ganter V., Krieger S., Lis S., Postler E., Voderholzer U., Berger M. Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin. Invest. 72:1994;315.
6. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Yok B., Berger M. Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. Fed. Eur. Biochem. Soc. 285:1991;111-114.
7. Benveniste, E.N. Role of cytokines in multiple sclerosis, autoimmune encephalitis, and other neurological disorders. In: Aggarwal, B. B., Puri, R. K., eds. Human cytokines: Their role in disease and therapy. Cambridge: Blackwell, 1995:195-215.
8. Bessler H., Karp L., Notti I., Apter A., Tyano S., Djaldetti M., Weizman R. Cytokine production in anorexia nervosa. Clin. Neuropharmacol. 16:1993;237-243.
9. Beyaert R., Schulze-Osthoff K., Van Roy F., Fiers W. Synergistic induction of interleukin-6 by tumor necrosis factor and lithium chloride in mice: Possible role in the triggering and exacerbation of psoriasis by lithium treatment. Eur. J. Immunol. 22:1992;2181-2184.
10. Blalock J.E. The syntax of immune-neuroendocrine communication. Immunol. Today. 15:1994;504-511.
11. Blatteis C.M. Neuromodulative actions of cytokines. Yale J. Biol. Med. 63:1990;133-146.
12. 2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro. Immunopharmacol. Immunotoxicol. 10:1988;501-512.
13. Breder C.D., Dinarello C.A., Saper C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science. 240:1988;321-324.
14. Calvet M.C., Greser Il Interferon enhances the excitability of cultured neurons. Nature. 278:1979;558-560.
15. Cannon J.G., Dinarello C.A. Increased plasma interleukin-1 activity in women after ovulation. Science. 227:1985;1247-1249.
16. Cantell K., Pulkkinen E., Elosuo R., Suominen J. Effect of interferon on severe psychiatric diseases. Ann. Clin. Res. 12:1980;131-132.
17. Chung I.Y., Benveniste E.N. Tumor necrosis factor α production by astrocytes: Induction by lipopolysaccharide, IFN-γ, and L-1β J. Immunol. 144:1990;2999-3007.
18. Cosman D., Lyman S.D., Idzerda R.L., Beckmann M.P., Park L.S., Goodwin R.G., March C.J. A new cytokine receptor superfamily. Trends Biochem. Sci. 15:1990;265-269.
19. da Cunha A., Vitković L. Transforming growth factor-beta 1 (TGF-b 1) expression and regulation in rat cortical astrocytes. J. Neuroimmunol. 36:1992;157-169.
20. Dafny N. Interferon modifies EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats. NeuroToxicol. 4:1983;235-240.
21. Denicoff K.D., Rubinow D.R., Papa M.Z., Simpson C., Seipp C.A., Lotze M.T., Chang A.E., Rosenstein D., Rosenberg S.A. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. Intern. Med. 107:1987;293-300.
22. DeSarro G.B., Masuda Y., Ascioti C., Audino M., Nistico G. Behavioral and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology. 20:1990;167-169.
23. Dinarello C.A., Gelfand J.A., Wolff S.M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. J. Am. Med. Assoc. 269:1993;1829-1835.
24. Dowers S.K. Cytokine receptor families. Adv. Second Messenger Phosphoprotein Res. 28:1993;19-25.
25. El-Mallakh R.S., Sudath R.L., Wyatt R.J. Interleukin-1α and interleukin-2 in cerebrospinal fluid of schizophrenic subjects. Prog. NeuroPsychopharmacol. Biol. Psychiatry. 17:1993;383-391.
26. Farkkila M., Iivanainen M., Roine R., Bergstrom, Laaksonen R., Niemi M.-L., Cantell K. Neurotoxic and other side effects of high-dose interferon in amyotrophic lateral sclerosis. Acta. Neurol. Scand. 70:1984;42-46.
27. Farrar W.L., Kilian P.L., Ruff M.R., Hill J.M., Pert C.B. Visualization and characterization of interleukin 1 receptors in brain. J. Immunol. 139:1987;459-463.
28. Farrar W.L., Vinocour M., Hill J.M. In situ hybridization histochemistry localization of interleukin-3 mRNA in mouse brian. Blood. 73:1989;137-140.
29. Fent K., Zbinden G. Toxicity of interferon and interleukin. Trends Pharmacol. Sci. 8:1987;100-105.
30. Fillit H., Dig W., Buee L., Kalman J., Altstiel L., Lawlor B., Wolf-Klein G. Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett. 129:1991;318-320.
31. 1 is an organizer of response to neurodegeneration. J. Cell Biochem. 53:1993;314-322.
32. Foxwell B.M.J., Barrett K., Feldmann M. Cytokine receptors: Structure and signal transduction. Clin. Exp. Immunol. 90:1992;161-169.
33. +) to enhance the production of colony stimulating factor (GM-CSF) from mitogen-stimulated lymphocytes in vitro. Cell. Immunol. 85:1984;58-66.
34. Ganguli R., Rabin B.S. Increased serum interleukin-2 receptor concentration in schizophrenic and brain-damaged subjects. Arch. Gen. Psychiatry. 46:1989;292.
35. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., Gajdusek C. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. Natl Acad. Sci. USA. 86:1989;7606-7610.
36. Glaser R., Kennedy S., Lafuse W.P., Bonneau R.H., Speicher C., Millhouse J., Kiecolt-Glaser J.K. Psychological stress-induced modulation of interleukin 2 receptor gene expression and interleukin 2 production in peripheral blood leukocytes. Arch. Gen. Psychiatry. 47:1990;707-712.
37. Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L. III, Araoz C. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA. 86:1989;7611-7615.
38. Hohagen F., Timmer J., Weyerbrock A., Fritsch-Montero R., Ganter U., Krieger S., Beryer M., Bauer J. Cytokine production during sleep and wakefulness and its relationship to cortisol in healthy humans. Neuropsychobiology. 28:1993;9-16.
39. Inglot A.D., Leszek J., Piasecki E., Sypula A. Interferon response in schizophrenia and major depressive disorders. Biol. Psychiatry. 35:1994;464-473.
40. Jablecki C., Cantell K., Connor J., Kinsbury D., Hamburger R., Westall F., Smith R. Experimental treatment of amyotrophic lateral sclerosis with interferon: Pharmacokinetic studies. Ann. Neurol. 10:1981;82.
41. Kleinerman E.S., Knowles R.D., Blick M.B., Zwelling L.A. Lithium chloride stimulates human monocytes to secrete tumor necrosis factor/cachectin. J. Leukocyte Biol. 46:1989;484-492.
42. Krueger J.M., Obal F. Jr., Opp M., Toth L., Johannsen L., Cady A.B. Somnogenic cytokines and models concerning their effects on sleep. Yale J. Biol. Med. 63:1990;157-172.
43. Lapchak P.A. A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport. 3:1992;165-168.
44. Lapchak P.A., Araujo D.M., Quirion R., Beaudet A. Immunoradiographic localization of interleukin-2-like immunoreactivity and interleukin-2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience. 44:1991;173-184.
45. Licinio J., Seibyl J.P., Altemus M., Charney D.S., Krystal J.H. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am. J. Psychiatry. 150:1993;1408-1410.
46. Lieberman A.P., Pitha P.M., Shin H.S., Shin M.L. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl Acad. Sci. USA. 86:1989;6348-6352.
47. Linkowski P., Mendelwicz J., LeClercq R., Brasseur M., Hubain P., Golstein J., Copinschi G., VanCauter E. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J. Clin. Endocrinol. Metab. 61:1985;429-438.
48. Maes M., Bosmans E., Meltzer H.Y., Scharpie S., Suy E. Interleukin-1β: A putative mediator of HPA axis hyperactivity in major depression? Am. J. Psychiatry. 150:1993;1189-1193.
49. Malipiero U.V., Frei K., Fontana A. Production of hematopoietic colony-stimulating factors by astrocytes. J. Immunol. 144:1990;3816-3821.
50. McAllister C.G., van Kammen D.P., Rehn T.J., Miller A.C., Gurklis J., Kelley M.E., Ydo J., Peters J.L. Increases in CSF levels of interleukin-2 in schizophrenia: Effects of recurrence of psychosis and medication status. Am J Psychiatry. 152:1995;1291-1297.
51. Merrill J.E. Interleukin-2 effects in the central nervous system. Ann. NY Acad. Sci. 594:1990;188-199.
52. Merrill J.E., Jonakait G.M. Interactions of the nervous and immune systems in development, normal brain homeostasis, and disease. Fed. Am. Socs Exp. Biol. 9:1995;611-618.
53. A receptor function in brain. Mol. Pharmacol. 39:1991;105-108.
54. Moldofsky H., Jiang C.G., Lue F.A., Gorczynski R.M. Nocturnal sleep-related production of interleukin-1 from peripheral blood mononuclear cells (PBMC) of young men. Sleep Res. 24:1995;30.
55. Mora J.S., Munsat T.L., Kao K.-P., Finison L.J., Hedlund W., Bradley G.A., Sceife R., Georgiade J.A. Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis. Neurology. 36:1986;1137-1140.
56. Niranen A., Laaksonen R., Iivanainen M., Mattson K., Farkkila M., Cantell K. Behavioral assessment of patients treated with alpha-interferon. Acta Psychiat. Scand. 78:1988;622-626.
57. Nistico G., DeSarro G. Is interleukin-2 a neuromodulator in the brain? Trends Neurosci. 14:1991;146-149.
58. Olschowka, J.A. Immunocytochemical methods for localization of cytokines in brain. In: De Souza, E. B., ed. Neurobiology of cytokines, part A. Methods in neurosciences. San Diego: Academic Press, 1993:100-111.
59. Opp M.R., Krueger J.M. Interleukin-1 is involved in response to sleep deprivation in the rabbit. Brain Res. 639:1994;57-65.
60. Palazzolo D.L., Quadir S.K. Interleukin-1 inhibits serotonin release from the hypothalamus in vitro. Life Sci. 51:1992;1797-1802.
61. Payne L.C., Obal F. Jr., Krueger J.M. Hypothalamic releasing hormone mediating the effects of interleukin-1 on sleep. J. Cell Biochem. 53:1993;309-313.
62. Plata-Salaman C., Borkoski J.P. Interleukin-8 modulates feeding by direct action in the central nervous system. Am. J. Physiol. 265:1993;R877-R882.
63. Plata-Salaman C.R., Oomura Y., Kai Y. Tumor necrosis factor and interleukin-1 β: Suppression of food intake by direct action in the central nervous system. Brain Res. 448:1988;106-114.
64. Rapaport M.H., McAllister C.G., Pickar D., Nelson D.L., Paul S.M. Elevated levels of soluble interleukin 2 receptors in schizophrenia. Arch. Gen. Psychiatry. 46:1989;291-292.
65. Rapaport M.H., Torrey E.F., McAllister C.G., Nelson D.L., Pickar D., Paul S.M. Increased serum soluble interleukin-2 receptors in schizophrenic monozygotic twins. Eur. Arch. Psychiat. Neurosci. 243:1993;7-10.
66. Renault F.P., Hoffnagle J.H., Parke Y., Mullin K.D., Peters M., Jones B., Rustagi V., Jones E.A. Psychiatric complications of long-term interferon alpha therapy. Arch. Intern. Med. 147:1987;1577-1580.
67. Rosenberg S.A., Yang J.C., Topalian S.L., Schwartzentruber D.J., Weber J.S., Parkinson D.R., Seipp C.A., Einhorn J.H., White D.E. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. J. Am. Med. Assoc. 271:1994;907-913.
68. Saris S.C., Rosenberg S.A., Friedman R.B., Rubin J.T., Barba D., Oldfield E.H. Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier. J. Neurosurg. 69:1988;29-34.
69. Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:1989;394-399.
70. Schattner A., Stienbock M., Tepper R., Schonofeld A., Vaisman N., Hahn T. Tumor necrosis factor production and cell mediated immunity in anorexia nervosa. Clin. Exp. Immunol. 79:1990;62-66.
71. Seidel A., Arolt V., Hungstiger M., Rink L., Behnisch A., Kirschner H. Cytokine production and serum proteins in depression. Scand. J. Immunol. 41:1995;534-538.
72. Sirota P., Fishman P., Elizar A., Djaldetty M. Lymphokine production in schizophrenic patients. Biol. Psychiatry. 27:1990;118A.
73. Smith E.M. Hormonal activities of cytokines. Chem. Immunol. 52:1992;154-169.
74. Smith R.S. The macrophage theory of depression. Med. Hypothesis. 35:1991;298-306.
75. Smith R.S. The immune system is a key factor in the etiology of psychosocial disease. Med. Hypothesis. 34:1992;49-57.
76. Sperner-Unterweger B., Gaggl S., Fleischhacker W.W., Barnas C., Herold M., Geissler D. Effects of clozapine on hematopoiesis and the cytokine system. Biol. Psychiatry. 34:1993;536-543.
77. Tancredi V., Zona C., Velotti F., Eusebi F., Santoni A. Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res. 525:1990;149-151.
78. Tedeschi B., Barrett J.N., Keane R.W. Astrocytes produce interferon that enhances the expression of H-2 antigen on a subpopulation of brain cells. J. Cell Biol. 102:1986;2244-2253.
79. Triozzi P.L., Rinehart J.J. Central nervous system toxicity of biological response modifiers. Ann. NY Acad. Sci. 594:1990;347-354.
80. van Duijn C.M., Hofman A., Nagelkerken L. Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease. Neurosci. Lett. 108:1990;350-354.
81. Villemain F., Chatenoud L., Galinowski A., Homo-Delarche F., Ginestet D., Loo H., Zarifian E., Bach J.-F. Aberrant T cell-mediated immunity in untreated schizophrenic patients: Deficient interleukin-2 production. Am. J. Psychiatry. 146:1989;609-616.
82. Villemain F., Chatenoud L., Guillibert E., Pelcier Y., Bach J.-F. Decreased production of interleukin-2 in schizophrenia. Ann. NY Acad. Sci. 496:1987;669-675.
83. Waltrip R.W. II, Carrigan D.R., Carpenter W.T. Jr. Immunopathology and viral reactivation. A general theory of schizophrenia. J. Nerv. Ment. Disord. 178:1990;729-738.
84. Weiss J.M., Sundar S.M., Becker K.J., Cierpial M.A. Behavioral and neural influences on cellular immune responses: Effects of stress and interleukin-1. J. Clin. Psychiatry. 50(5(Suppl)):1989;44-52.
85. Weizman R., Laor N., Podliszewski E., Notti I., Djaldetti M., Bessler H. Cytokine production in major depressed patients before and after clomipramine treatment. Biol. Psychiatry. 35:1994;42-47.
86. Wicher J.T., Evans S.W. Cytokines in disease. Clin. Chem. 36:1990;1269-1281.
87. Wu Y.Y., Yang X.H. Induction of interleukin 2 production in human T cells following in vitro treatment with lithium. Lymphokine Res. 9:1990;601.
88. Xu H-M., Wei J., Hemmings G.P. Changes of plasma concentrations of interleukin-1a and interleukin-6 with neuroleptic treatment for schizophrenia. Br J Psychiatry. 164:1994;251-253.
89. Yolken R.H., Torrey E.F. Viruses, schizophrenia, and bipolar disorder. Clin. Microbiol. Rev. 8:1995;131-145.